Clinical Trial Update: Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED) [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update evaluates combining relugolix and darolutamide for prostate cancer after long-course androgen deprivation therapy. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Nubeqa (darolutamide)
• ORGOVYX (RELUGOLIX)

Snippet

Sponsor: Atish Choudhury, MD | Conditions: Prostate Cancer, Advanced Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING